FF An, XH Zhang - Theranostics, 2017 - ncbi.nlm.nih.gov
Biosafety is the primary concern in clinical translation of nanomedicine. As an intrinsic ingredient of human blood without immunogenicity and encouraged by its successful clinical …
Albumin, a versatile protein carrier for drug delivery, has been shown to be nontoxic, non- immunogenic, biocompatible and biodegradable. Therefore, it is ideal material to fabricate …
M Karimi, S Bahrami, SB Ravari… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: One of the biggest impacts that the nanotechnology has made on medicine and biology, has been in the area of drug delivery systems (DDSs). Many drugs suffer from …
Abstract Design and synthesis of efficient drug delivery systems are of vital importance for medicine and healthcare. Nanocarrier-based drug delivery systems, in particular …
Aim: A novel biomimetic strategy was employed for presenting antibodies on gold nanorods (NRs) to target growth factor receptors on cancer cells for use in photothermal therapy …
B Bhushan, V Khanadeev, B Khlebtsov… - Advances in colloid and …, 2017 - Elsevier
Abstracts A major challenge in the field of nanomedicine is to transform laboratory innovations into commercially successful clinical products. In this campaign, a variety of …
Albumin nanovectors represent one of the most promising carriers recently generated because of the cost-effectiveness of their fabrication, biocompatibility, safety, and versatility …
S Lamichhane, S Lee - Archives of pharmacal research, 2020 - Springer
Albumin is a biocompatible, non-immunogenic and versatile drug carrier system. It has been widely used to extend the half-life, enhance stability, provide protection from degradation …
M Wacker - International journal of pharmaceutics, 2013 - Elsevier
Nanodispersed drug delivery systems for the intravenous injection have successfully overcome the hurdle of drug approval in the European Union and the United States …